62 views
Bruna Maldonado, founding partner and scientific director of ImunoTera Soluções Terapêuticas, talks about the company, which was created by scientists trained at USP and aims to transform basic research into health products for the benefit of society. The specialist also details the development of therapeutic vaccines against diseases caused by HPV, the results already obtained in the experimental model and also in a clinical proof of concept. The CTVacinas Seminar Series is a series of lectures launched in 2023: usually on Wednesdays, an international reference is invited to give a seminar in the BH-TEC auditorium. Follow the official CTVacinas channels to check the seminar schedule. Instagram: www.instagram.com/ctvacinas LinkedIn: www.linkedin.com/company/ct-vacinas Website: www.ctvacinas.ufmg.br